You are here
,

Early approval of Alnylam's gene-silencing drug in question

  • Friday, 28 September 2018
  • Posted by Aftab Ahmad
  • 0 Comments
Alnylam Pharmaceuticals Inc said on Thursday it might have to hold off on plans to seek an accelerated approval for its gene-silencing drug, which showed effectiveness in a late-stage trial based on early data.


from Reuters: Health News https://ift.tt/2xTjUni

Aftab Ahmad

We are.., This is a short description in the author block about the author. You edit it by entering text in the "Biographical Info" field in the user admin panel.

No comments:

Leave a Reply